DVA
75
-2
OXY
40
3
MS
70
-2
EXR
66
2
LYB
43
2
GT
69
5
PM
64
-2
ROP
65
2
FFIV
67
-2
HP
50
4
CVX
40
-6
PLD
58
2
RSG
74
-2
ADBE
51
-10
BWA
50
2
ORCL
55
-10
GOOGL
50
2
CMI
64
-4
LB
63
3
CPB
37
-3
DVA
75
-2
OXY
40
3
MS
70
-2
EXR
66
2
LYB
43
2
GT
69
5
PM
64
-2
ROP
65
2
FFIV
67
-2
HP
50
4
CVX
40
-6
PLD
58
2
RSG
74
-2
ADBE
51
-10
BWA
50
2
ORCL
55
-10
GOOGL
50
2
CMI
64
-4
LB
63
3
CPB
37
-3
Financhill
Back

ProShares UltraShort MidCap400 Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
17

MZZ
ProShares UltraShort MidCap400

Last Price:
8.44
Seasonality Move:
-13.36%
Buy
60

SRPT
Sarepta Therapeutics

Last Price:
138.01
Seasonality Move:
14.88%
Sell
17
ProShares UltraShort MidCap400 (MZZ) is a Sell

Is ProShares UltraShort MidCap400 a Buy, Sell or Hold?

  • The current ProShares UltraShort MidCap400 [MZZ] share price is $8.51. The Score for MZZ is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
  • MZZ is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $137.94. The Score for SRPT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MZZ Stock Price Chart

What is ProShares UltraShort MidCap400's stock price today?

  • The ProShares UltraShort MidCap400 share price today is $8.51
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $137.94
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

MZZ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 32.16 Sell
Chaikin Money Flow: 3195 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.75 - 9.83) Sell
Bollinger Bands (100): (9.41 - 10.97) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.37 Sell
Relative Strength Index (14 RSI): 69.97 Buy
Chaikin Money Flow: 2429824 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (110.85 - 129.69) Buy
Bollinger Bands (100): (119.21 - 142.01) Buy

MZZ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.88 Sell
20-day SMA: 9.14 Sell
50-day SMA: 9.58 Sell
200-day SMA: 10.81 Sell
8-day EMA: 8.76 Sell
20-day EMA: 9.08 Sell
50-day EMA: 9.55 Sell
200-day EMA: 10.97 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 116.25 Buy
20-day SMA: 117.78 Buy
50-day SMA: 122.17 Buy
200-day SMA: 130.04 Buy
8-day EMA: 121.1 Buy
20-day EMA: 119.12 Buy
50-day EMA: 122.54 Buy
200-day EMA: 126.1 Buy

ProShares UltraShort MidCap400 Earnings Growth & MZZ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.

ProShares UltraShort MidCap400 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):